AKBA vs GNRC · rev $102.7M vs P/E 82, rev $1.17B
Akebia Ther (AKBA) versus Generac Holdings Inc (GNRC) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported GNRC revenue for 2026-06-30 was $1.17B. Net income was $143.2M. Revenue was up 10.8% from 2026-03-31 to 2026-06-30. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
AKBA currently screens at market cap $260.1M. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Not investment advice. Open the AKBA and GNRC stock pages for the full models.
Not investment advice.